Medicine and Dentistry
Human Immunodeficiency Virus
100%
Infection
75%
Disease
35%
COVID-19
33%
Hepatitis C Virus
17%
Antiretroviral Therapy
17%
Transplantation
17%
Intensive Care Unit
16%
Antibiotics
15%
Human Immunodeficiency Virus Infection
14%
Surgical Infection
14%
Odds Ratio
13%
Cohort Effect
13%
Antiinfective Agent
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Hepatitis C
12%
Infection Prevention
12%
Hepatitis B Virus
11%
Health Care
11%
Healthcare Associated Infection
10%
Prevalence
10%
Outpatient
9%
Cohort Analysis
9%
Osteomyelitis
9%
Pathogen
8%
Diabetic Foot
8%
Infective Endocarditis
8%
Staphylococcus Aureus
8%
Mixed Infection
8%
Pediatrics
8%
Health Care Cost
8%
Substance Use
7%
Infection Control
7%
Antimicrobial Therapy
7%
Placebo
7%
Catheter Infection
6%
Hepatitis B
6%
Urinary Tract Infection
6%
Antivirus Agent
6%
Vancomycin
6%
Liver Disease
6%
Prospective Cohort Study
6%
Kidney Graft
6%
Symptom
6%
Immunosuppressive Treatment
6%
Emergency Department
6%
Diagnosis
5%
Organ Transplantation
5%
Rheumatology
5%
Primary Health Care
5%
Public Health
5%
Randomized Controlled Trial
5%
Highly Active Antiretroviral Therapy
5%
Bacteremia
5%
Clinician
5%
Gene Linkage
5%
Malignant Neoplasm
5%
Horizontal Disease Transmission
5%
Biopsy
5%
Randomized Clinical Trial
5%
Lung Transplantation
5%
Health System
5%
Systematic Review
5%
Cardiovascular Disease
5%
Rheumatic Disease
5%
Substance Use Disorder
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
79%
Infection
55%
Disease
33%
Cohort Study
14%
Antiinfective Agent
12%
Vancomycin
12%
Coronavirinae
12%
Hepatitis B Virus
12%
SARS Coronavirus
11%
Antibiotics
11%
Human Immunodeficiency Virus Infection
10%
Placebo
10%
Antibiotic Agent
9%
Hepatitis C Virus
9%
Mixed Infection
9%
Infectious Agent
8%
Staphylococcus Aureus
8%
Vaccination Policy
8%
Methicillin-Resistant Staphylococcus Aureus
7%
Clinical Trial
7%
Hepatitis B
7%
Hepatitis C
7%
Surgical Infection
6%
Methicillin Resistant Staphylococcus Aureus Infection
6%
Prevalence
6%
Antimicrobial Therapy
6%
Comorbidity
5%
Adverse Event
5%
Bacteremia
5%
Prospective Cohort Study
5%
Biological Marker
5%
Ethanol
5%
Bacterial Endocarditis
5%
Statin (Protein)
5%
Respiratory Tract Disease
5%
Keyphrases
AIDS/HIV
18%
COVID-19
15%
Confidence Interval
13%
People Living with HIV (PLHIV)
11%
United States
10%
Methicillin-resistant Staphylococcus Aureus
8%
Risk Factors
8%
HIV Patients
7%
Antiretroviral Therapy
6%
Healthcare-associated Infections
5%
Vancomycin-resistant Enterococci
5%
Osteomyelitis
5%
Antibiotics
5%
Clinical Outcomes
5%
HIV Infection
5%
Rheumatic Diseases
5%
American College of Rheumatology
5%
Odds Ratio
5%